GeoVax Stock Is Trading Higher On Gedeptin In-Licensing Pact For Solid Tumors
GeoVax Labs Inc (NASDAQ:GOVX) entered into a license agreement with PNP Therapeutics Inc to develop and commercialize Gedeptin for solid tumors. The transaction’s…